Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mamputu, J.-C.
Right arrow Articles by Renier, G.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation

Jean-Claude Mamputu

CHUM Research Centre, Notre-Dame Hospital, Department of Nutrition, University of Montreal, Montreal, Canada

Nicolas Wiernsperger

Merck-Santé, 37, rue Saint Romain, 69379 Lyon, France

Geneviève Renier

CHUM Research Centre, Notre-Dame Hospital, Department of Nutrition, University of Montreal, Montreal, Canada, genevieve.renier{at}umontreal.ca

The United Kingdom Prospective Diabetes Study (UKPDS) found that metformin reduces macrovascular complications in type 2 diabetic patients. To investigate the mechanisms involved we examined the effect of metformin on monocyte adhesion to human endothelial cells (ECs) induced by advanced glycation end-products (AGE), and on monocyte differentiation into macrophages and foam cell formation. Treatment of human ECs with AGEs (100 µg/ml) for up to 12 hours significantly increased human monocyte adhesion. Pre-treatment of the cells with metformin (0.1—2.5 µg/ml) inhibited AGE-induced monocyte adhesion and expression of endothelial cell adhesion molecules. In culture, human monocytes spontaneously differentiated into macrophages, as indicated by phenotypic changes, and increased expression of lectin-like oxidised low-density lipoprotein (LDL) receptor and scavenger receptor type A. Incubation of these cells in the presence of metformin decreased expression of all of these parameters. Metformin also inhibited foam cell formation induced by minimally modified LDL. Overall, these results suggest new mechanisms by which metformin may reduce the risk of vascular complications in patients with type 2 diabetes.

Key Words: metformin • monocyte adhesion • advanced glycation end-products • adhesion molecules • macrophages • foam cells.

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 4, 302-310 (2003)
DOI: 10.1177/14746514030030041501
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
N. F Wiernsperger
Review: 50 years later: is metformin a vascular drug with antidiabetic properties?
The British Journal of Diabetes & Vascular Disease, September 1, 2007; 7(5): 204 - 210.
[Abstract] [PDF]

Home page
 DiabetesHome page
L. Li, J.-C. Mamputu, N. Wiernsperger, and G. Renier
Signaling Pathways Involved in Human Vascular Smooth Muscle Cell Proliferation and Matrix Metalloproteinase-2 Expression Induced by Leptin: Inhibitory Effect of Metformin
Diabetes, July 1, 2005; 54(7): 2227 - 2234.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. E. Caballero, A. Delgado, C. A. Aguilar-Salinas, A. N. Herrera, J. L. Castillo, T. Cabrera, F. J. Gomez-Perez, and J. A. Rull
The Differential Effects of Metformin on Markers of Endothelial Activation and Inflammation in Subjects with Impaired Glucose Tolerance: A Placebo-Controlled, Randomized Clinical Trial
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3943 - 3948.
[Abstract] [Full Text] [PDF]